medsurfnews - andrologia - should males be vaccinated against hpv?

Andrologia

Should males be vaccinated against HPV?

The association between human papillomavirus virus (HPV) and several cancers has prompted experts to ponder whether HPV vaccination programmes should be extended to males. In the USA, an estimated 20 000 cases of cancer are caused by HPV infection every year. Aside from cervical cancer, the virus is also implicated in head and neck, anal, penile, vaginal, and vulval cancers. The combined incidence of these cancers equals that of cervical cancer. A quarter of cases of HPV-related cancers occur in men.
Approfondisci

http://www.thelancet.com/journals/lanonc/article/PIIS1470204...

The Lancet Oncology

Ultime risorse da The Lancet Oncology

Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study (Oncologia)
Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China (Oncologia)
New drugs for aggressive B-cell and T-cell lymphomas (Oncologia)
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues (Oncologia)
Uncertain future for US embryonic stem-cell research (Oncologia)
Visualizza tutte le risorse di The Lancet Oncology